Lee KP - Search Results

1

KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells.

Mannava S, Zhuang D, Nair JR, Bansal R, Wawrzyniak JA, Zucker SN, Fink EE, Moparthy KC, Hu Q, Liu S, Boise LH, Lee KP, Nikiforov MA. Mannava S, et al. Among authors: lee kp. Blood. 2012 Feb 9;119(6):1450-8. doi: 10.1182/blood-2011-04-346676. Epub 2011 Dec 5. Blood. 2012. PMID: 22144178 Free PMC article.

2

Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells.

Fink EE, Mannava S, Bagati A, Bianchi-Smiraglia A, Nair JR, Moparthy K, Lipchick BC, Drokov M, Utley A, Ross J, Mendeleeva LP, Savchenko VG, Lee KP, Nikiforov MA. Fink EE, et al. Among authors: lee kp. Leukemia. 2016 Jan;30(1):104-11. doi: 10.1038/leu.2015.190. Epub 2015 Jul 24. Leukemia. 2016. PMID: 26205085 Free PMC article.

3

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma.

Murray ME, Gavile CM, Nair JR, Koorella C, Carlson LM, Buac D, Utley A, Chesi M, Bergsagel PL, Boise LH, Lee KP. Murray ME, et al. Among authors: lee kp. Blood. 2014 Jun 12;123(24):3770-9. doi: 10.1182/blood-2013-10-530964. Epub 2014 Apr 29. Blood. 2014. PMID: 24782505 Free PMC article.

4

The fatty acid elongase ELOVL6 regulates bortezomib resistance in multiple myeloma.

Lipchick BC, Utley A, Han Z, Moparthy S, Yun DH, Bianchi-Smiraglia A, Wolff DW, Fink E, Liu L, Furdui CM, Lee J, Lee KP, Nikiforov MA. Lipchick BC, et al. Among authors: lee kp, lee j. Blood Adv. 2021 Apr 13;5(7):1933-1946. doi: 10.1182/bloodadvances.2020002578. Blood Adv. 2021. PMID: 33821992 Free PMC article.

5

BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.

Morales AA, Gutman D, Lee KP, Boise LH. Morales AA, et al. Among authors: lee kp. Blood. 2008 May 15;111(10):5152-62. doi: 10.1182/blood-2007-10-116889. Epub 2008 Mar 19. Blood. 2008. PMID: 18354037 Free PMC article.

6

Novel inhibition of PIM2 kinase has significant anti-tumor efficacy in multiple myeloma.

Nair JR, Caserta J, Belko K, Howell T, Fetterly G, Baldino C, Lee KP. Nair JR, et al. Among authors: lee kp. Leukemia. 2017 Aug;31(8):1715-1726. doi: 10.1038/leu.2016.379. Epub 2016 Dec 23. Leukemia. 2017. PMID: 28008178 Free PMC article.

7

CD28 expressed on malignant plasma cells induces a prosurvival and immunosuppressive microenvironment.

Nair JR, Carlson LM, Koorella C, Rozanski CH, Byrne GE, Bergsagel PL, Shaughnessy JP Jr, Boise LH, Chanan-Khan A, Lee KP. Nair JR, et al. Among authors: lee kp. J Immunol. 2011 Aug 1;187(3):1243-53. doi: 10.4049/jimmunol.1100016. Epub 2011 Jun 29. J Immunol. 2011. PMID: 21715687 Free PMC article.

8

Under one roof: The bone marrow survival niche for multiple myeloma and normal plasma cells.

Nair JR, Rozanski CH, Lee KP. Nair JR, et al. Among authors: lee kp. Oncoimmunology. 2012 May 1;1(3):388-389. doi: 10.4161/onci.18746. Oncoimmunology. 2012. PMID: 22737625 Free PMC article.

9

Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.

Matulis SM, Morales AA, Yehiayan L, Lee KP, Cai Y, Boise LH. Matulis SM, et al. Among authors: lee kp. PLoS One. 2012;7(12):e52662. doi: 10.1371/journal.pone.0052662. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23285138 Free PMC article.

10

The Tao of myeloma.

Boise LH, Kaufman JL, Bahlis NJ, Lonial S, Lee KP. Boise LH, et al. Among authors: lee kp. Blood. 2014 Sep 18;124(12):1873-9. doi: 10.1182/blood-2014-05-578732. Blood. 2014. PMID: 25097176 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

673 results

Search Page